Pfizer Strikes $70 Billion Deal with U.S. to Expand Its mRNA Empire, Lower Drug Prices

‘Landmark agreement’ lets Pfizer expand its disastrous mRNA platform — sweeping a massive trail of death and destruction under the rug.